Recombinant COVID-19 vaccine (Sf9 cells)

· WestVac Biopharma Co., Ltd.

Drug timelines are a Plus or Pro feature.

2 regulatory and trial events tracked for Recombinant COVID-19 vaccine (Sf9 cells), covering 2025-03-26 to 2025-03-28. Get the full timeline:

Most recent: Clinical Trial Update: Clinical Trial of Recombinant COVID-19 Vaccine (Sf9 Cells) in Children and Adolescents [Phase 1, Phase 2]